ASPO Plc STOCK EXCHANGE RELEASE April 10, 2014 at 14.15 Advance information on Aspo Group's net sales and operating profit in January- March 2014 Aspo: Operating profit increased rapidly and stood at EUR 3.8 million (January- March 2013: EUR 0.9 million) in Q1. General market situation It has been estimated that the general risk level has increased in the market area of Russia, Ukraine and other CIS countries, particularly due to the weakening of local currencies and a slowdown in economic growth. The profitability of Russia-linked companies is expected to have weakened. Aspo's net sales and operating profit Q1 More than 30% of Aspo Group's net sales consist of the markets of Russia, Ukraine and other CIS countries. Compared to the comparison period, the Russian ruble and the Ukrainian hryvnia weakened to a great extent, which decreased Aspo's euro-denominated net sales. Currency exchange rate changes did not substantially decrease Aspo's operating profit. According to initial non-audited information, Aspo Group's net sales for Q1 were EUR 108 million (January-March 2013: EUR 112.3 million) and operating profit increased to a substantial extent, being EUR 3.8 million (0.9). Business segments ESL Shipping, Kaukomarkkinat and Telko improved their operating profit to a significant extent. Leipurin improved its profitability in bakery raw materials, but due to the later timing of machine deliveries, the operating profit of Leipurin decreased in Q1 when measured against the comparison period. Aspo Group's operating loss not belonging to the business operations grew compared to the comparison period. Measured in euros, Leipurin grew substantially in the markets of Russia, Ukraine and other CIS countries in January-March, and the operating profit percentage of bakery raw materials, an important area for the company, remained over 5%. At Telko, the decline of the Russian economy has had a negative impact on the demand for Telko products. Despite this, ruble-denominated net sales were higher than in the same period in the previous year. The Russian ruble weakened, which decreased euro-denominated net sales. The operating profit percentage in the markets of Russia, Ukraine and other CIS countries exceeded 5%. The political crisis in Ukraine and Russia has decreased Telko's business volume in Ukraine, but the relative profitability of the business in Ukraine has improved from the previous quarter, and has remained at a good level in Russia. Aspo's guidance for 2014 The Aspo guidance remains unchanged: Aspo will improve its operating profit. The interim report for January-March 2014 will be published on 5 May 2014 at about 10.00 am. Helsinki April 10, 2014 ASPO Plc Aki Ojanen CEO For more information: Aki Ojanen, CEO of Aspo Plc, tel. +358 9 5211, +358 400 106 592 Aspo is a conglomerate that owns and develops businesses in Northern Europe and growth markets focusing on demanding B-to-B customers. The aim of our strong corporate brands - ESL Shipping, Leipurin, Telko and Kaukomarkkinat - is to be the market leaders in their sectors. They are responsible for their own operations, customer relationships and the development of these. Together they generate Aspo's goodwill. Aspo's Group structure and business operations are developed persistently without any predefined schedules. DISTRIBUTION: NASDAQ OMX Helsinki Key media www.aspo.com [HUG#1776355]
Advance information on Aspo Group's net sales and operating
Top 10 Most Recent News Articles
Quantum Space Joins $185M NASA Lunar Transport Deal
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom
The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....
Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit
Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...
Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
Novo's Semaglutide Shows Promise in MASH Study
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue ReadingTop 5 Most Recently Viewed Articles
Sonic Partners with Obsessed Garage for Home Garage Solutions
Sonic Teams Up with Obsessed Garage to Transform Home Garages Sonic, a front-runner in delivering high-quality tool solutions and equipment, has recently announced an exciting partnership with Obsessed Garage. This collaboration aims to cater to home garage enthusiasts who demand tools and storage solutions that match the quality standards utilized by professionals in the...
Continue Reading
Investors of Sun Communities, Inc. Urged to Act Before Deadline
Important Update for Sun Communities, Inc. Investors There is a significant call to action for investors of Sun Communities, Inc. as a class action lawsuit has been filed against the company, urging those affected to act promptly. This is a crucial moment for investors who purchased securities from the company during a specific period. Legal representation is being...
Continue Reading
XOMA Stock Reaches New Heights: Key Developments and Insights
XOMA Stock Performance Overview XOMA Ltd's stock has recently made headlines by reaching a remarkable 52-week high, with shares trading at an impressive $30.49. This achievement not only signifies a significant milestone for the company but also highlights a robust year-over-year growth that can't be overlooked. Investors have observed a substantial increase of 73.82% in...
Continue Reading
Evolv Technologies Faces Turmoil with Executive Departures
Evolv Technologies Faces Turmoil with Executive Departures Evolv Technologies Holdings (NASDAQ: EVLV) is navigating turbulent times following the resignation of its Chief Financial Officer, Mark Donohue. His departure comes amid serious allegations of improper revenue recognition practices that have raised questions about the company's integrity and financial health....
Continue Reading
Editas Medicine: Financial Insights and Market Strategies Revealed
Editas Medicine Maintains Price Target Amidst Financial Developments Recently, Leerink Partners reaffirmed a Market Perform rating for Editas Medicine (NASDAQ: EDIT), keeping a price target steady at $8.00. This decision comes closely after the company announced a substantial financing agreement with DRI Healthcare Trust. Under this agreement, Editas is set to receive an...
Continue Reading